Genomic Medicine: Genomic Medicine -- An Updated Primer.

被引:270
作者
Feero, W. Gregory [1 ,4 ]
Guttmacher, Alan E. [2 ]
Collins, Francis S. [3 ]
机构
[1] NHGRI, NIH, Bethesda, MD 20892 USA
[2] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, NIH, Bethesda, MD USA
[3] NIH, Off Director, Bethesda, MD 20892 USA
[4] Maine Dartmouth Family Med Residency Program, Augusta, GA USA
关键词
MOLECULAR-ORIGINS; SEQUENCE; EPIGENETICS; SIGNATURES; CANCER; WILL;
D O I
10.1056/NEJMra0907175
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cathy, a 40-year-old mother of three, arrives in your office for her annual physical. She has purchased a commercial genomewide scan (see the Glossary), which she believes measures the clinically meaningful risk that common diseases will develop, and has completed her family history online using My Family Health Portrait (www.familyhistory.hhs.gov), a tool developed for this purpose by the U.S. Surgeon General. Her genomewide scan suggests a slightly elevated risk of breast cancer, but you correctly recognize that this information is of unproven value in routine clinical care. On importing Cathy's family-history file, your office's electronic health record system alerts you to the fact that Cathy is of Ashkenazi Jewish heritage and has several relatives with breast cancer, putting her at heightened risk for the hereditary breast and ovarian cancer syndrome. The system prompts you to discuss Cathy's risk of breast and ovarian cancer during the visit. Considering both her family history and ancestry, you refer Cathy to a health care professional with advanced genetics training for consultation. In the coming months Cathy elects to have her DNA tested for mutations in BRCA1 and BRCA2, the genes associated with hereditary breast and ovarian cancer syndrome, and to undergo a mammographic examination. Although the results of her genetic tests are negative, her mammogram reveals a suspicious abnormality. A biopsy is performed, and breast cancer is detected. Surgery is successful. Pathological examination of tissue from the excised tumor reveals that it is positive for estrogen-receptor protein and negative for human epidermal growth factor receptor type 2 (HER2); the lymph glands are free of cancer cells. Genetic-expression profiling of the tumor indicates a relatively high risk of recurrent cancer, and Cathy elects to receive adjuvant chemotherapy followed by treatment with tamoxifen. Five years later, the cancer has not recurred. Copyright © 2010 Massachusetts Medical Society.
引用
收藏
页码:2001 / 2011
页数:11
相关论文
共 49 条
  • [1] A haplotype map of the human genome
    Altshuler, D
    Brooks, LD
    Chakravarti, A
    Collins, FS
    Daly, MJ
    Donnelly, P
    Gibbs, RA
    Belmont, JW
    Boudreau, A
    Leal, SM
    Hardenbol, P
    Pasternak, S
    Wheeler, DA
    Willis, TD
    Yu, FL
    Yang, HM
    Zeng, CQ
    Gao, Y
    Hu, HR
    Hu, WT
    Li, CH
    Lin, W
    Liu, SQ
    Pan, H
    Tang, XL
    Wang, J
    Wang, W
    Yu, J
    Zhang, B
    Zhang, QR
    Zhao, HB
    Zhao, H
    Zhou, J
    Gabriel, SB
    Barry, R
    Blumenstiel, B
    Camargo, A
    Defelice, M
    Faggart, M
    Goyette, M
    Gupta, S
    Moore, J
    Nguyen, H
    Onofrio, RC
    Parkin, M
    Roy, J
    Stahl, E
    Winchester, E
    Ziaugra, L
    Shen, Y
    [J]. NATURE, 2005, 437 (7063) : 1299 - 1320
  • [2] MicroRNAs: Novel Biomarkers for Human Cancer
    Bartels, Claudine L.
    Tsongalis, Gregory J.
    [J]. CLINICAL CHEMISTRY, 2009, 55 (04) : 623 - 631
  • [3] Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project
    Birney, Ewan
    Stamatoyannopoulos, John A.
    Dutta, Anindya
    Guigo, Roderic
    Gingeras, Thomas R.
    Margulies, Elliott H.
    Weng, Zhiping
    Snyder, Michael
    Dermitzakis, Emmanouil T.
    Stamatoyannopoulos, John A.
    Thurman, Robert E.
    Kuehn, Michael S.
    Taylor, Christopher M.
    Neph, Shane
    Koch, Christoph M.
    Asthana, Saurabh
    Malhotra, Ankit
    Adzhubei, Ivan
    Greenbaum, Jason A.
    Andrews, Robert M.
    Flicek, Paul
    Boyle, Patrick J.
    Cao, Hua
    Carter, Nigel P.
    Clelland, Gayle K.
    Davis, Sean
    Day, Nathan
    Dhami, Pawandeep
    Dillon, Shane C.
    Dorschner, Michael O.
    Fiegler, Heike
    Giresi, Paul G.
    Goldy, Jeff
    Hawrylycz, Michael
    Haydock, Andrew
    Humbert, Richard
    James, Keith D.
    Johnson, Brett E.
    Johnson, Ericka M.
    Frum, Tristan T.
    Rosenzweig, Elizabeth R.
    Karnani, Neerja
    Lee, Kirsten
    Lefebvre, Gregory C.
    Navas, Patrick A.
    Neri, Fidencio
    Parker, Stephen C. J.
    Sabo, Peter J.
    Sandstrom, Richard
    Shafer, Anthony
    [J]. NATURE, 2007, 447 (7146) : 799 - 816
  • [4] Intra-individual change over time in DNA methylation with familial clustering
    Bjornsson, Hans T.
    Sigurdsson, Martin I.
    Fallin, M. Daniele
    Irizarry, Rafael A.
    Aspelund, Thor
    Cui, Hengmi
    Yu, Wenqiang
    Rongione, Michael A.
    Ekstrom, Tomas J.
    Harris, Tamara B.
    Launer, Lenore J.
    Eiriksdottir, Gudny
    Leppert, Mark F.
    Sapienza, Carmen
    Gudnason, Vilmundur
    Feinberg, Andrew P.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 299 (24): : 2877 - 2883
  • [5] The complete genome sequence of Escherichia coli K-12
    Blattner, FR
    Plunkett, G
    Bloch, CA
    Perna, NT
    Burland, V
    Riley, M
    ColladoVides, J
    Glasner, JD
    Rode, CK
    Mayhew, GF
    Gregor, J
    Davis, NW
    Kirkpatrick, HA
    Goeden, MA
    Rose, DJ
    Mau, B
    Shao, Y
    [J]. SCIENCE, 1997, 277 (5331) : 1453 - +
  • [6] The potential and challenges of nanopore sequencing
    Branton, Daniel
    Deamer, David W.
    Marziali, Andre
    Bayley, Hagan
    Benner, Steven A.
    Butler, Thomas
    Di Ventra, Massimiliano
    Garaj, Slaven
    Hibbs, Andrew
    Huang, Xiaohua
    Jovanovich, Stevan B.
    Krstic, Predrag S.
    Lindsay, Stuart
    Ling, Xinsheng Sean
    Mastrangelo, Carlos H.
    Meller, Amit
    Oliver, John S.
    Pershin, Yuriy V.
    Ramsey, J. Michael
    Riehn, Robert
    Soni, Gautam V.
    Tabard-Cossa, Vincent
    Wanunu, Meni
    Wiggin, Matthew
    Schloss, Jeffery A.
    [J]. NATURE BIOTECHNOLOGY, 2008, 26 (10) : 1146 - 1153
  • [7] Origins and Mechanisms of miRNAs and siRNAs
    Carthew, Richard W.
    Sontheimer, Erik J.
    [J]. CELL, 2009, 136 (04) : 642 - 655
  • [8] The promises and pitfalls of RNA-interference-based therapeutics
    Castanotto, Daniela
    Rossi, John J.
    [J]. NATURE, 2009, 457 (7228) : 426 - 433
  • [9] *CHIMP SEQ AN CONS, 2005, NATURE, V0437
  • [10] Lineage-Specific Biology Revealed by a Finished Genome Assembly of the Mouse
    Church, Deanna M.
    Goodstadt, Leo
    Hillier, LaDeana W.
    Zody, Michael C.
    Goldstein, Steve
    She, Xinwe
    Bult, Carol J.
    Agarwala, Richa
    Cherry, Joshua L.
    DiCuccio, Michael
    Hlavina, Wratko
    Kapustin, Yuri
    Meric, Peter
    Maglott, Donna
    Birtle, Zoe
    Marques, Ana C.
    Graves, Tina
    Zhou, Shiguo
    Teague, Brian
    Potamousis, Konstantinos
    Churas, Christopher
    Place, Michael
    Herschleb, Jill
    Runnheim, Ron
    Forrest, Daniel
    Amos-Landgraf, James
    Schwartz, David C.
    Cheng, Ze
    Lindblad-Toh, Kerstin
    Eichler, Evan E.
    Ponting, Chris P.
    [J]. PLOS BIOLOGY, 2009, 7 (05):